Specific Keynote: Hereditary Ovarian Cancer: What We Know
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 88 (1) , S8-S10
- https://doi.org/10.1006/gyno.2002.6674
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian CancerAmerican Journal of Human Genetics, 2001
- Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutationsHuman Mutation, 2000
- BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian CancerAmerican Journal of Human Genetics, 2000
- Oral Contraceptives and the Risk of Hereditary Ovarian CancerNew England Journal of Medicine, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13American Journal of Human Genetics, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Contribution ofBRCA1Mutations to Ovarian CancerNew England Journal of Medicine, 1997
- Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locusNature Genetics, 1996
- Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutationHuman Molecular Genetics, 1995